12-4273870-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000674624.1(ENSG00000285901):​n.-171C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.58 in 661,906 control chromosomes in the GnomAD database, including 112,200 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 25784 hom., cov: 31)
Exomes 𝑓: 0.58 ( 86416 hom. )

Consequence

ENSG00000285901
ENST00000674624.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.88

Publications

19 publications found
Variant links:
Genes affected
CCND2 (HGNC:1583): (cyclin D2) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with CDK4 or CDK6 and functions as a regulatory subunit of the complex, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. Knockout studies of the homologous gene in mouse suggest the essential roles of this gene in ovarian granulosa and germ cell proliferation. High level expression of this gene was observed in ovarian and testicular tumors. Mutations in this gene are associated with megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3). [provided by RefSeq, Sep 2014]
CCND2-AS1 (HGNC:49398): (CCND2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 12-4273870-C-T is Benign according to our data. Variant chr12-4273870-C-T is described in ClinVar as Benign. ClinVar VariationId is 678294.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.688 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCND2NM_001759.4 linkc.-171C>T 5_prime_UTR_variant Exon 1 of 5 ENST00000261254.8 NP_001750.1
CCND2-AS1NR_125790.1 linkn.126+2189G>A intron_variant Intron 1 of 1
CCND2-AS1NR_149145.1 linkn.182+1426G>A intron_variant Intron 1 of 3
CCND2-AS1NR_149146.1 linkn.182+1426G>A intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000285901ENST00000674624.1 linkn.-171C>T non_coding_transcript_exon_variant Exon 1 of 10 ENSP00000501898.1
CCND2ENST00000261254.8 linkc.-171C>T 5_prime_UTR_variant Exon 1 of 5 1 NM_001759.4 ENSP00000261254.3
ENSG00000285901ENST00000674624.1 linkn.-171C>T 5_prime_UTR_variant Exon 1 of 10 ENSP00000501898.1

Frequencies

GnomAD3 genomes
AF:
0.580
AC:
88116
AN:
151860
Hom.:
25742
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.557
Gnomad AMI
AF:
0.698
Gnomad AMR
AF:
0.667
Gnomad ASJ
AF:
0.624
Gnomad EAS
AF:
0.708
Gnomad SAS
AF:
0.461
Gnomad FIN
AF:
0.544
Gnomad MID
AF:
0.639
Gnomad NFE
AF:
0.575
Gnomad OTH
AF:
0.600
GnomAD4 exome
AF:
0.579
AC:
295474
AN:
509928
Hom.:
86416
Cov.:
6
AF XY:
0.575
AC XY:
153040
AN XY:
266150
show subpopulations
African (AFR)
AF:
0.555
AC:
7428
AN:
13394
American (AMR)
AF:
0.686
AC:
12792
AN:
18654
Ashkenazi Jewish (ASJ)
AF:
0.631
AC:
8830
AN:
13984
East Asian (EAS)
AF:
0.633
AC:
19742
AN:
31180
South Asian (SAS)
AF:
0.481
AC:
22831
AN:
47452
European-Finnish (FIN)
AF:
0.541
AC:
16289
AN:
30088
Middle Eastern (MID)
AF:
0.609
AC:
1276
AN:
2094
European-Non Finnish (NFE)
AF:
0.583
AC:
189541
AN:
325014
Other (OTH)
AF:
0.597
AC:
16745
AN:
28068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
7184
14368
21551
28735
35919
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1960
3920
5880
7840
9800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.580
AC:
88219
AN:
151978
Hom.:
25784
Cov.:
31
AF XY:
0.581
AC XY:
43193
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.557
AC:
23087
AN:
41428
American (AMR)
AF:
0.667
AC:
10194
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.624
AC:
2167
AN:
3470
East Asian (EAS)
AF:
0.707
AC:
3642
AN:
5150
South Asian (SAS)
AF:
0.461
AC:
2217
AN:
4806
European-Finnish (FIN)
AF:
0.544
AC:
5751
AN:
10578
Middle Eastern (MID)
AF:
0.646
AC:
190
AN:
294
European-Non Finnish (NFE)
AF:
0.575
AC:
39061
AN:
67948
Other (OTH)
AF:
0.603
AC:
1273
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1853
3706
5559
7412
9265
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
746
1492
2238
2984
3730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.594
Hom.:
29595
Bravo
AF:
0.599
Asia WGS
AF:
0.617
AC:
2147
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.4
DANN
Benign
0.58
PhyloP100
1.9
PromoterAI
0.021
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1049606; hg19: chr12-4383036; COSMIC: COSV54222306; COSMIC: COSV54222306; API